Bhagirath Place under scanner: 204 samples of syrups, medicines and surgical items lifted for testing

Bhagirath Place under scanner

Published On 2025-12-16 12:07 GMT | Update On 2025-12-16 12:07 GMT

New Delhi: The Delhi government has stepped up its fight against spurious medicines with a focused enforcement drive at Bhagirath Place.

On Monday, the teams of Drugs Control Department of Delhi government fanned out across the market, inspecting 27 wholesale drug dealers operating in the area. The operation resulted in the lifting of 204 samples of syrups, medicines and surgical items.

More than 10 firms were found contravening provisions of the Drugs Rules, and necessary action has been initiated against the defaulting firms under the provisions of the Drugs and Cosmetics Act and Rules, it added.

To verify compliance with prescribed quality and safety standards, 204 samples of syrups, medicines, cotton and other surgical items were lifted during the inspections and sent for sample testing and analysis, PTI reported.

During the drive at Bhagirath Palace, one shop was booked for the sale of medical devices/surgical items without a valid licence, a clear violation of the Medical Devices Rules. Appropriate action is being taken against the erring firm.

Earlier, acting on specific inputs received from the Cyber Cell, Crime Branch, Delhi Police, a joint team of the Drugs Control Department and Delhi Police conducted a late-night raid at a drug trading premises at Teliwara in Sadar Bazar.

The operation led to the detection and seizure of a large quantity of counterfeit and spurious medicines and anti-fungal cream from one of the drug traders, the statement said.

During the raid, the premises were found to be operating without a valid drug licence, and the person in charge failed to produce any purchase or sale records. Physical verification revealed large quantities of fake branded topical formulations stocked for sale and distribution, it said.

Preliminary investigation revealed that the seized counterfeit medicines were being supplied to adjacent states and neighbouring countries. In view of this, the Drugs Control Departments of the concerned neighbouring states have been formally informed about the malpractice for necessary vigilance and coordinated action.

Delhi Health Minister Pankaj Singh said such intensified enforcement drives will continue across the city to curb the sale of spurious, substandard and illegally sold drugs and medical devices.

Read also: UP Launches Statewide Crackdown on Illegal Codeine Trade, 128 FIRs Registered

Article Source : With inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bhagirath Place under scanner: 204 samples of syrups, medicines and surgical items lifted for testing

Bhagirath Place under scanner

Similar News

Counterfeit medicines, raw materials worth over Rs 2.3 crore seized including tubes of spurious Betnovate-C ointment

Senores Pharma to buy Apnar Pharma at enterprise value of Rs 91 crore

Zydus-owned Sentynl's Menkes disease drug NDA resubmission accepted by USFDA

AstraZeneca-Daiichi Sankyo Enhertu Combo wins USFDA approval for 1st-line HER2-Positive Metastatic Breast Cancer

Lupin secures SBTi validation for emission reduction targets

Parliamentary Panel Raps DoP, NPPA for 5-Year Delay in Trade Margin Rationalisation Under DPCO

AI Boosts Indian Pharma's Global Competitiveness, but Cost, Time Gains Unquantified, Parliament Told